Biomarkers in diagnosis and therapy of oral squamous cell carcinoma: A review of the literature

Summary Oral squamous cell carcinoma (OSCC) represents the sixth most common cancer, accounting for 2-4% of all malignancies worldwide. The overall survival rate of less than 60% remains generally poor, with prognosis heavily relying on the TNM staging system. Tumor size as well as the presence and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of cranio-maxillo-facial surgery 2017-05, Vol.45 (5), p.722-730
Hauptverfasser:	Blatt, Sebastian, DMD, Krüger, Maximilian, MD, DMD, Ziebart, Thomas, MD, DMD, PhD, Sagheb, Keyvan, MD, DMD, Schiegnitz, Eik, MD, DMD, Goetze, Elisabeth, Al-Nawas, Bilal, MD, DMD, PhD, Pabst, Andreas Max, MD, DMD
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - therapeutic use Biomarker Biomarkers, Tumor - blood Carcinoma, Squamous Cell - blood Carcinoma, Squamous Cell - diagnosis Carcinoma, Squamous Cell - drug therapy Dentistry Diagnosis Drug Resistance, Neoplasm Humans Mouth Neoplasms - blood Mouth Neoplasms - diagnosis Mouth Neoplasms - drug therapy Oral cancer Oral squamous cell carcinoma OSCC Prognosis Surgery Therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!